HVEM/TNFRSF14 Antibody (2742B) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # FAB3563JF669
Recombinant Monoclonal Antibody.
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Neutralization
Label
Janelia Fluor 669
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 2742B
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Human embryonic kidney cell HEK293-derived human HVEM/TNFRSF14
Pro37-Val202
Accession # Q92956
Pro37-Val202
Accession # Q92956
Specificity
Detects human HVEM/TNFRSF14 in ELISA.
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for HVEM/TNFRSF14 Antibody (2742B) [Janelia Fluor® 669]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Neutralization
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: HVEM/TNFRSF14
Long Name
Herpesvirus Entry Mediator
Alternate Names
ATAR, CD270, LIGHTR, TNFRSF14
Additional HVEM/TNFRSF14 Products
Product Documents for HVEM/TNFRSF14 Antibody (2742B) [Janelia Fluor® 669]
Product Specific Notices for HVEM/TNFRSF14 Antibody (2742B) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...